Oppenheimer Lowers PT on Genpact to $19
Oppenheimer is out with its report today on Genpact (NYSE: G), lowering its PT to $19 from $20.
In its report, Oppenheimer writes, "We are slightly revising our estimates and price target for Genpact. Our FY11 estimates are now 1.573B/$0.86 from $1.574B/$0.88. For FY12 our estimates are lowered to $1.864B/$1.00 from prior $1.887B/$1.04. We are subsequently lowering our price target for Genpact from prior $20 to $19 to reflect lower estimates."
Oppenheimer maintains Outpeform on G.
At the time of posting, shares of G were trading at $16.13, up 1.57% from Friday's close.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.